A detailed history of Jane Street Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 160,452 shares of ABBV stock, worth $28.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
160,452
Previous 458,364 64.99%
Holding current value
$28.9 Million
Previous $78.6 Million 59.7%
% of portfolio
0.01%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $48.8 Million - $59.4 Million
-297,912 Reduced 64.99%
160,452 $31.7 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $20.2 Million - $23.6 Million
130,416 Added 39.77%
458,364 $78.6 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $1.55 Million - $1.76 Million
-9,673 Reduced 2.87%
327,948 $59.7 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $28.2 Million - $31.7 Million
-204,836 Reduced 37.76%
337,621 $52.3 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $31.1 Million - $36 Million
232,598 Added 75.07%
542,457 $80.9 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $19.9 Million - $24.8 Million
150,289 Added 94.18%
309,859 $41.7 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $24.7 Million - $28.5 Million
-171,068 Reduced 51.74%
159,570 $25.4 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $634,704 - $761,177
4,589 Added 1.41%
330,638 $53.5 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $355,924 - $408,222
2,652 Added 0.82%
326,049 $43.8 Million
Q2 2022

Aug 16, 2022

BUY
$137.62 - $174.96 $21.5 Million - $27.3 Million
156,016 Added 93.21%
323,397 $49.5 Million
Q1 2022

May 17, 2022

SELL
$131.98 - $163.75 $25.2 Million - $31.2 Million
-190,574 Reduced 53.24%
167,381 $27.1 Million
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $6.12 Million - $7.74 Million
-56,970 Reduced 13.73%
357,955 $48.5 Million
Q3 2021

Nov 16, 2021

SELL
$106.4 - $120.78 $2.48 Million - $2.81 Million
-23,262 Reduced 5.31%
414,925 $44.8 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $170,545 - $189,997
1,621 Added 0.37%
438,187 $49.4 Million
Q1 2021

May 18, 2021

BUY
$102.3 - $112.62 $19.1 Million - $21 Million
186,886 Added 74.85%
436,566 $47.2 Million
Q4 2020

Feb 17, 2021

BUY
$80.49 - $108.67 $16.4 Million - $22.2 Million
204,342 Added 450.71%
249,680 $26.8 Million
Q3 2020

Nov 17, 2020

SELL
$85.91 - $100.83 $2.07 Million - $2.42 Million
-24,044 Reduced 34.65%
45,338 $3.97 Million
Q2 2020

Aug 17, 2020

BUY
$73.37 - $98.18 $2.77 Million - $3.7 Million
37,686 Added 118.9%
69,382 $6.81 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $5.47 Million - $8.29 Million
-84,813 Reduced 72.8%
31,696 $2.42 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $3.2 Million - $4.01 Million
-44,421 Reduced 27.6%
116,509 $10.3 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $15.9 Million - $19.2 Million
-252,980 Reduced 61.12%
160,930 $12.2 Million
Q2 2019

Aug 15, 2019

BUY
$65.7 - $83.98 $18.5 Million - $23.7 Million
282,326 Added 214.56%
413,910 $30.1 Million
Q1 2019

May 16, 2019

BUY
$77.14 - $90.79 $8.32 Million - $9.79 Million
107,805 Added 453.36%
131,584 $10.6 Million
Q4 2018

Feb 15, 2019

SELL
$77.85 - $96.01 $3.65 Million - $4.5 Million
-46,832 Reduced 66.32%
23,779 $2.19 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $9.27 Million - $10.3 Million
-104,218 Reduced 59.61%
70,611 $6.68 Million
Q2 2018

Aug 15, 2018

BUY
$89.78 - $106.23 $9.48 Million - $11.2 Million
105,637 Added 152.67%
174,829 $16.2 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $26.5 Million - $35.5 Million
-287,779 Reduced 80.62%
69,192 $6.55 Million
Q4 2017

Feb 15, 2018

BUY
$89.56 - $98.21 $25.2 Million - $27.6 Million
281,060 Added 370.25%
356,971 $34.5 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $5.3 Million - $6.77 Million
75,911
75,911 $6.75 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.